Tuesday, June 06, 2017 -- New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017.
Saturday, July 08, 2017 -- A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections. Brian VanderVen, assistant professor of microbiology and immunology, along with colleagues at Cornell’s College of Veterinary Medicine have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which could lead to new drugs for treating tuberculosis. The findings […] The post Tuberculosis: Cornell discovery could lead to a new, effective treatments appeared first on Outbreak News Today.
Friday, November 17, 2017 -- A close-up image of Mycobacterium tuberculosis, the pathogen responsible for TB.
Monday, January 15, 2018 -- (Natural News) A study discovered that the ethanolic leaf extracts of the plant Rubia cordifolia or Indian madder contain anti-mycobacterial, cytotoxic, and antioxidant activities, which can be used in fighting against mycobacterial tuberculosis infection. A team of researchers from the University of Limpopo in South Africa analyzed the protective effects of Rubia cordifolia, more commonly known... Read More
Saturday, September 02, 2017 -- Previously thought to be effective for 10-15 years, a new case-control study found that if given in early teenage years (12-13), the Bacillus Calmette-Guérin (BCG) vaccine protected over 50% of UK children against TB for at least 20 years, then waned. The research was led by the London School of Hygiene & Tropical Medicine and […] The post TB: BCG vaccine protective for nearly twice as long as previously thought appeared first on Outbreak News Today.
Monday, January 01, 2018 -- An X-ray of the lung of a suspected tuberculosis patient in Vietnam. Researchers say urine testing for tuberculosis, which kills 1.7 million people a year, may soon be possible.
Friday, September 01, 2017 -- At a state laboratory at Albany, N.Y., a worker fills a vial with BCG, or Bacillus Calmette-Guérin, a vaccine against tuberculosis, in 1947.
Monday, October 16, 2017 -- Alberta Health Services is notifying hundreds of people that they were potentially exposed to a confirmed case of tuberculosis in the Edmonton area. A total of 323 people are receiving letters about their potential exposure to TB at an unnamed continuing care facility, AHS said in a Monday news release. The letters inform people how […]
Friday, October 13, 2017 -- Tuberculosis patients in Khayelitsha, South Africa, waited to see doctors. A study of patients in four countries, including South Africa, showed that a shorter treatment region could be effective against drug-resistant tuberculosis.
Friday, September 01, 2017 -- Previously thought to be effective for 10-15 years, a new case-control study found that if given in early teenage years (12-13), the Bacillus Calmette-Guérin (BCG) vaccine protected over 50% of UK children against TB for at least 20 years, then waned.
Wednesday, December 13, 2017 -- Sometimes projects don’t work the way you want or need them to the first time, and as the saying goes, if at first you don’t succeed, try, try again. The Global Good Fund, a collaboration... View the entire article via our website.
Saturday, June 24, 2017 -- A newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB). This is the finding of a team of scientists from Cardiff University’s School of Biosciences and the University of Warwick.
Tuesday, January 09, 2018 -- Between February and November 2016, the Institute of Medical Microbiology at the University of Zurich discovered a multidrug-resistant Mycobacterium tuberculosis in eight refugees arriving in Europe from the Horn of Africa.
Monday, August 21, 2017 -- Researchers find that performing a TB diagnostic test in a clinic as opposed to a centralized laboratory greatly reduced patients’ time to treatment.
Monday, November 27, 2017 -- In a recent study, researchers investigate whether there is an association between poorly controlled diabetes and tuberculosis. For centuries, healthcare providers have recognized that there is an association between diabetes and tuberculosis. In fact, patients with diabetes are considered to have a higher potential risk of developing tuberculosis (TB). The reason for this being that […] The post What is the Relationship between Diabetes and Tuberculosis? appeared first on Medical News Bulletin | Health News and Medical Research.
Wednesday, October 25, 2017 -- Scientists in China and the US have discovered that tuberculosis management in rural China lags behind the national and international standards.
Friday, December 01, 2017 -- A new study provides data on the “know-do” and “policy-practice” gaps found in tuberculosis diagnosis and care across three levels of China’s health system. What is Tuberculosis? Tuberculosis, or TB, is a disease caused by bacteria called Mycobacterium tuberculosis. A tuberculosis diagnosis includes detecting symptoms of fever, night sweats, coughing, hemoptysis (coughing up sputum stained […] The post Tuberculosis Diagnosis and Care in China: A Lesson for All appeared first on Medical News Bulletin | Health News and Medical Research.
Friday, January 05, 2018 -- A new study has found that anti-tuberculosis drugs killed more bacteria in laboratory mice given a vitamin C supplement than those given drugs alone. If the findings hold up in human studies, the authors say, the result could be that there's a cheap, safe way to reduce the months-long treatment time for one of the world's leading killers. Also, the vitamin supplement could offer a way to cut down on the development of drug-resistant TB, a serious health threat. Tuberculosis is one of the leading causes of death worldwide. According to the World Health Organization, 1.7 million people died of the disease last year. Of more than 10 million new infections, about 600,000 were resistant to the leading drug. Front-line
Friday, July 07, 2017 -- A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.
Monday, July 10, 2017 -- Mycobacterium tuberculosis (Mtb), with its mere ~4,000 genes, has been outsmarting us for decades. One look at the numbers illustrates this clearly. The disease caused by Mtb, tuberculosis (TB), is one of the top ten causes of death in the world. It currently infects roughly 1.5 billion people worldwide and causes 1.8 million deaths every year - most commonly in India, Indonesia, China, Nigeria, Pakistan and South Africa.